Dr. Purificación Muñoz, a researcher at the IDIBELL (Oncobell Program), has been awarded with the V Martí Vía Prize for cancer research, an award given annually by the Vallformosa Foundation and GESCO Family. The grant is endowed with 30,000 euros. This amount is assigned, year after year, to professionals and researchers from areas related to pediatric …
The researcher Purificación Muñoz receives the V Martí Via prize Read More »
Screening programs allow to detect the disease when it is in its initial stages to treat it in time and increase the chances of cure. Despite its benefits, there may be a small group of patients who may suffer the consequences of a ‘false positive’, this means that the blood found in the stool may be due to benign pathologies and not cancer.
Once the period for applications submission is finished, all the documentation provided has been reviewed and the list for funded EoI is approved. The Assessment Committee, met on October 8th, in accordance with the criteria described in the call, has evaluated the Collaborative Projects and has raised a list of proposals selected to be funded. …
Dr. Silvia de Sanjosé (IDIBELL-ICO) has been recently recognized as a Highly Cited Researcher. She leads the Infections and Cancer group, whose research focuses on the fight between viruses and hosts from an evolutionary perspective: the antiviral mechanisms which animals have developed and the antiviral strategies which have contributed to virus selection. They explore the …
The company ADmit Therapeutics S.L. The spin-off of the Bellvitge Biomedical Research Institute (IDIBELL) that works toward developing a test for the early detection of Alzheimer’s disease (AD), has just received two important sources of funding through competitive calls from the Spanish Ministry of Science, Innovation and Universities. Specifically, he has been awarded a Torres …
ADmit Therapeutics receives strong boost from competitive aid Read More »
Researchers at Bellvitge Biomedical Research Institute will develop a research project with the company Pharmacelera to look for new molecules that block the cohesin complex, with applications in several difficult-to-treat cancers, such as myeloid leukemia, glioblastomas, Ewing sarcomas, colon cancer and bladder cancer
More than 300 people attended the festival of research & innovation on health, held at IDIBELL.
Saturday, November 16, from 10 a.m. to 2 p.m., open day at the facilities of the Duran i Reynals Hospital. This event wants to showcase the responsible and innovative research carried out at the Bellvitge Biomedical Pole
The conference on health innovation Innovation for value, held on November 8 in Barcelona, has analyzed the opportunities offered by technological advances in the field of health. The conference, organized by the Bellvitge Biomedical Research Institute (IDIBELL) and the Platform for Innovation in Medical and Health Technologies (ITEMAS), has been attended by some of the …
Innovation for value analyzes the use of big data and the new power it gives to patients Read More »
On the occasion of the Spanish Congress of Cardiology, a meeting of the researchers participating in the project has taken place. The project is part of a territorial program that integrates hospital and primary care
